Return On Equity of MADRIGAL PHARMACEUTICALS, INC. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -42%, a 42% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. annual Return On Equity for 2024 was -58%, a 74% increase from 2023.
  • MADRIGAL PHARMACEUTICALS, INC. annual Return On Equity for 2023 was -219%, a 19% increase from 2022.
  • MADRIGAL PHARMACEUTICALS, INC. annual Return On Equity for 2022 was -270%, a 169% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -42% +30% +42% 01 Jul 2025 30 Sep 2025
Q2 2025 -38% +57% +60% 01 Apr 2025 30 Jun 2025
Q1 2025 -51% +78% +61% 01 Jan 2025 31 Mar 2025
Q4 2024 -58% +162% +74% 01 Oct 2024 31 Dec 2024
Q3 2024 -72% +222% +76% 01 Jul 2024 30 Sep 2024
Q2 2024 -96% +190% +67% 01 Apr 2024 30 Jun 2024
Q1 2024 -129% +156% +55% 01 Jan 2024 31 Mar 2024
Q4 2023 -219% +51% +19% 01 Oct 2023 31 Dec 2023
Q3 2023 -294% -42% -17% 01 Jul 2023 30 Sep 2023
Q2 2023 -286% -131% -84% 01 Apr 2023 30 Jun 2023
Q1 2023 -285% -168% -145% 01 Jan 2023 31 Mar 2023
Q4 2022 -270% -170% -169% 01 Oct 2022 31 Dec 2022
Q3 2022 -251% -157% -167% 01 Jul 2022 30 Sep 2022
Q2 2022 -155% -68% -78% 01 Apr 2022 30 Jun 2022
Q1 2022 -117% -39% -51% 01 Jan 2022 31 Mar 2022
Q4 2021 -101% -36% -56% 01 Oct 2021 31 Dec 2021
Q3 2021 -94% -46% -97% 01 Jul 2021 30 Sep 2021
Q2 2021 -87% -53% -157% 01 Apr 2021 30 Jun 2021
Q1 2021 -77% -52% -212% 01 Jan 2021 31 Mar 2021
Q4 2020 -64% -45% -241% 01 Oct 2020 31 Dec 2020
Q3 2020 -48% -33% -224% 01 Jul 2020 30 Sep 2020
Q2 2020 -34% -22% -192% 01 Apr 2020 30 Jun 2020
Q1 2020 -25% -16% -185% 01 Jan 2020 31 Mar 2020
Q4 2019 -19% -11% -133% 02 Oct 2019 31 Dec 2019
Q3 2019 -15% -6% -64% 01 Jul 2019 30 Sep 2019
Q2 2019 -12% +2% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -9% +18% +67% 01 Jan 2019 31 Mar 2019
Q4 2018 -8% +29% +78% 01 Oct 2018 31 Dec 2018
Q3 2018 -9% 01 Jul 2018 30 Sep 2018
Q2 2018 -13% 01 Apr 2018 30 Jun 2018
Q1 2018 -27% 01 Jan 2018 31 Mar 2018
Q4 2017 -37% 01 Oct 2017 31 Dec 2017

MADRIGAL PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -58% +162% +74% 01 Jan 2024 31 Dec 2024
2023 -219% +51% +19% 01 Jan 2023 31 Dec 2023
2022 -270% -170% -169% 01 Jan 2022 31 Dec 2022
2021 -101% -36% -56% 01 Jan 2021 31 Dec 2021
2020 -64% -45% -241% 01 Jan 2020 31 Dec 2020
2019 -19% -11% -133% 01 Jan 2019 31 Dec 2019
2018 -8% +29% +78% 01 Jan 2018 31 Dec 2018
2017 -37% +29% +43% 01 Jan 2017 31 Dec 2017
2016 -66% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.